Volume 25, Number 6—June 2019
Research
Assessment of Economic Burden of Concurrent Measles and Rubella Outbreaks, Romania, 2011–2012
Table 5
Estimated overall cost per case of measles, rubella, or congenital rubella syndrome during concurrent outbreaks, Romania, 2011–2012*
Cost type |
Cost per case (sensitivity analysis lower bound–upper bound; 2013 US $) |
||
---|---|---|---|
Measles |
Rubella, not CRS |
CRS |
|
Household direct medical and nonmedical | $71 ($21–$127) | $19 ($6–$46) | NA |
Household indirect | $63 ($47–$86) | $42 ($34–$57) | NA |
Healthcare provider | $264 ($237–290) | $27 ($25–30) | NA |
National outbreak response | $42 ($37–46) | $42 ($38–47) | NA |
CRS cases direct medical | NA | NA | $4,820 ($1,742–$7,191) |
CRS cases lifetime discounted indirect | NA | NA | $39,231 (UB: $80,195) |
Estimated total societal/case | $439 ($389–494) | $132 ($118–$158) | $44,051 ($40,973–$85,015) |
*CRS, congenital rubella syndrome; NA, not applicable; UB, upper bound of sensitivity analysis.
1Current affiliation: JoDon Consulting Group LLC, Atlanta, Georgia, USA.
2Current affiliation: Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Page created: May 20, 2019
Page updated: May 20, 2019
Page reviewed: May 20, 2019
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.